QR-Code

Differences in biomarker testing in non-small cell lung cancer: real-world outcomes within an integrated healthcare system

IntroductionWhile biomarker testing can guide lung cancer treatment, its real-world application in community practice remains underexplored. This study examines the prevalence, predictors, and outcomes of biomarker testing in non-small cell lung cancer (NSCLC).MethodsThis retrospective cohort study...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: William P. Carroway, Nathan J. Alcasid, Alberto Jarrin Lopez, Kenneth Williams, Varada Sarovar, Huyun Dong, Wendy Dyer, Jingrong Yang, Lori C. Sakoda, Jeffrey B. Velotta
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2025-11-01
Schriftenreihe:Frontiers in Surgery
Schlagworte:
non-small cell lung cancer (NSCLC)
biomarker testing
next-generation sequencing(NGS)
survival outcomes
health disparities
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fsurg.2025.1632360/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge